Vip Patel

Array ( [id] => 4296733 [patent_doc_number] => 06180772 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-30 [patent_title] => 'Nucleic acids encoding dominant negative I-.kappa.-B -.alpha. polypeptides' [patent_app_type] => 1 [patent_app_number] => 9/064713 [patent_app_country] => US [patent_app_date] => 1998-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4486 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/180/06180772.pdf [firstpage_image] =>[orig_patent_app_number] => 064713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4184848 [patent_doc_number] => 06020464 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'Isolated Smad protein' [patent_app_type] => 1 [patent_app_number] => 9/063893 [patent_app_country] => US [patent_app_date] => 1998-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7296 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/020/06020464.pdf [firstpage_image] =>[orig_patent_app_number] => 063893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3974342 [patent_doc_number] => 05916804 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-29 [patent_title] => 'Method for site-specific integration of nucleic acids and related products' [patent_app_type] => 1 [patent_app_number] => 9/062375 [patent_app_country] => US [patent_app_date] => 1998-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 13074 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/916/05916804.pdf [firstpage_image] =>[orig_patent_app_number] => 062375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3915184 [patent_doc_number] => 06001971 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Human transcription factor' [patent_app_type] => 1 [patent_app_number] => 9/059520 [patent_app_country] => US [patent_app_date] => 1998-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18682 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001971.pdf [firstpage_image] =>[orig_patent_app_number] => 059520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4231313 [patent_doc_number] => 06117638 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-12 [patent_title] => 'Methods to screen for transcription factor-coactivator interactions' [patent_app_type] => 1 [patent_app_number] => 9/054238 [patent_app_country] => US [patent_app_date] => 1998-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 12401 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/117/06117638.pdf [firstpage_image] =>[orig_patent_app_number] => 054238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4083848 [patent_doc_number] => 06025182 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Method for producing a virus from an african green monkey kidney cell line' [patent_app_type] => 1 [patent_app_number] => 9/048308 [patent_app_country] => US [patent_app_date] => 1998-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16607 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025182.pdf [firstpage_image] =>[orig_patent_app_number] => 048308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3940643 [patent_doc_number] => 05989897 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Yeast silencing genes proteins and methods' [patent_app_type] => 1 [patent_app_number] => 9/047026 [patent_app_country] => US [patent_app_date] => 1998-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23515 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/989/05989897.pdf [firstpage_image] =>[orig_patent_app_number] => 047026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4416054 [patent_doc_number] => 06194168 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Expression control sequences' [patent_app_type] => 1 [patent_app_number] => 9/044796 [patent_app_country] => US [patent_app_date] => 1998-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4522 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/194/06194168.pdf [firstpage_image] =>[orig_patent_app_number] => 044796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4044997 [patent_doc_number] => 05908780 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-01 [patent_title] => 'Cells transformed or transfected with HCMV US2 gene' [patent_app_type] => 1 [patent_app_number] => 9/039802 [patent_app_country] => US [patent_app_date] => 1998-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 55 [patent_no_of_words] => 12712 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/908/05908780.pdf [firstpage_image] =>[orig_patent_app_number] => 039802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3977776 [patent_doc_number] => 05917029 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-29 [patent_title] => 'Sugar-responsive enhancers in .alpha.-amylase genes' [patent_app_type] => 1 [patent_app_number] => 9/038227 [patent_app_country] => US [patent_app_date] => 1998-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10999 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/917/05917029.pdf [firstpage_image] =>[orig_patent_app_number] => 038227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4043601 [patent_doc_number] => 05912129 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-15 [patent_title] => 'Multi-zone polymerase/ligase chain reaction' [patent_app_type] => 1 [patent_app_number] => 9/035091 [patent_app_country] => US [patent_app_date] => 1998-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 10370 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/912/05912129.pdf [firstpage_image] =>[orig_patent_app_number] => 035091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4084973 [patent_doc_number] => 06017758 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-25 [patent_title] => 'DMNPE caged nucleic acid and vector' [patent_app_type] => 1 [patent_app_number] => 9/026794 [patent_app_country] => US [patent_app_date] => 1998-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9975 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/017/06017758.pdf [firstpage_image] =>[orig_patent_app_number] => 026794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4379049 [patent_doc_number] => 06277566 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Method for identifying a hedgehog-mediated phosphorylation state dependent transcription factor' [patent_app_type] => 1 [patent_app_number] => 9/023249 [patent_app_country] => US [patent_app_date] => 1998-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 23 [patent_no_of_words] => 15462 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 207 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277566.pdf [firstpage_image] =>[orig_patent_app_number] => 023249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3977615 [patent_doc_number] => 05917019 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-29 [patent_title] => 'Altered telomere repeat binding factor 2' [patent_app_type] => 1 [patent_app_number] => 9/018628 [patent_app_country] => US [patent_app_date] => 1998-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 69 [patent_no_of_words] => 49358 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/917/05917019.pdf [firstpage_image] =>[orig_patent_app_number] => 018628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4293238 [patent_doc_number] => 06184038 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Transport proteins and their uses' [patent_app_type] => 1 [patent_app_number] => 9/011073 [patent_app_country] => US [patent_app_date] => 1998-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 8111 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/184/06184038.pdf [firstpage_image] =>[orig_patent_app_number] => 011073 [rel_patent_id] =>[rel_patent_doc_number] =>)